COVID-19 Vaccination and Remdesivir are Associated With Protection From New or Increased Levels of Donor-Specific Antibodies Among Kidney Transplant Recipients Hospitalized With COVID-19.

Saved in:
Bibliographic Details
Title: COVID-19 Vaccination and Remdesivir are Associated With Protection From New or Increased Levels of Donor-Specific Antibodies Among Kidney Transplant Recipients Hospitalized With COVID-19.
Authors: Killian JT Jr; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Houp JA; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Burkholder GA; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Roman Soto SA; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Killian AC; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Ong SC; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Erdmann NB; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Goepfert PA; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Hauptfeld-Dolejsek V; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Leal SM Jr; Department of Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Zumaquero E; Department of Microbiology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Nellore A; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Agarwal G; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Kew CE; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Orandi BJ; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Locke JE; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Porrett PM; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Levitan EB; School of Public Health, University of Alabama at Birmingham, Birmingham, AL, United States., Kumar V; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Lund FE; Department of Microbiology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Source: Transplant international : official journal of the European Society for Organ Transplantation [Transpl Int] 2022 Jul 19; Vol. 35, pp. 10626. Date of Electronic Publication: 2022 Jul 19 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S. A Country of Publication: Switzerland NLM ID: 8908516 Publication Model: eCollection Cited Medium: Internet ISSN: 1432-2277 (Electronic) Linking ISSN: 09340874 NLM ISO Abbreviation: Transpl Int Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-2277
DOI:10.3389/ti.2022.10626